Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ExoAtlet-II

K-Number: K201473 · 2021-07-16

Decision Date2021-07-16
Product CodePHL
Advisory CommitteePM
DecisionSubstantially Equivalent

Device Summary

ExoAtlet-II is a medical device manufactured by Exoatlet Asia Co. , Ltd.. It received FDA 510(k) clearance on 2021-07-16 under approval number K201473. The device is classified under product code PHL. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ExoAtlet-II?

ExoAtlet-II is a medical device that received FDA 510(k) clearance on 2021-07-16. It is manufactured by Exoatlet Asia Co. , Ltd.. The 510(k) number is K201473.

When was ExoAtlet-II approved by the FDA?

ExoAtlet-II received FDA 510(k) clearance on 2021-07-16, under approval number K201473.

What company makes ExoAtlet-II?

ExoAtlet-II is manufactured by Exoatlet Asia Co. , Ltd..

What is the FDA product code for ExoAtlet-II?

The FDA product code for ExoAtlet-II is PHL.

Related Devices (Code: PHL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.